Files
2026-07-06 17:28:36 -04:00

8.2 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Pharmacists; initiating of treatment with and dispensing and administering of controlled substances. Pharmacists; prescribing, dispensing, and administration of controlled substances. Allows a pharmacist to initiate treatment with and dispense and administer certain drugs and devices to persons 18 years of age or older in accordance with a statewide protocol developed by the Board of Pharmacy in collaboration with the Board of Medicine and the Department of Health. The bill directs the Board of Pharmacy to establish such protocols by November 1, 2020, to promulgate emergency regulations to implement the provisions of the bill, and to convene a work group to provide recommendations regarding the development of protocols for the initiating of treatment with and dispensing and administering of additional drugs and devices for persons 18 years of age and older. The bill also clarifies that an accident and sickness insurance policy that provides reimbursement for a service that may be legally performed by a licensed pharmacist shall provide reimbursement for the initiating of treatment with and dispensing and administration of controlled substances by a pharmacist when such initiating of treatment with or dispensing or administration is in accordance with regulations of the Board of Pharmacy. us/states/va Virginia General Assembly 2020 HB 1506 Virginia HB 1506 (2020)
bill
enacted
Mark D. Sickles
6 46 9 2020-01-08 2020-04-06 openstates ocd-bill/a2f3a038-9cdb-4837-b7d5-5aaba7759216 https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+HB1506 f6522265e6f7a9eb5920414292d7274074b4d6adbcfc71bccfa3b43dad33ace5 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia HB 1506 (2020) — Pharmacists; initiating of treatment with and dispensing and administering of controlled substances.

Pharmacists; prescribing, dispensing, and administration of controlled substances. Allows a pharmacist to initiate treatment with and dispense and administer certain drugs and devices to persons 18 years of age or older in accordance with a statewide protocol developed by the Board of Pharmacy in collaboration with the Board of Medicine and the Department of Health. The bill directs the Board of Pharmacy to establish such protocols by November 1, 2020, to promulgate emergency regulations to implement the provisions of the bill, and to convene a work group to provide recommendations regarding the development of protocols for the initiating of treatment with and dispensing and administering of additional drugs and devices for persons 18 years of age and older. The bill also clarifies that an accident and sickness insurance policy that provides reimbursement for a service that may be legally performed by a licensed pharmacist shall provide reimbursement for the initiating of treatment with and dispensing and administration of controlled substances by a pharmacist when such initiating of treatment with or dispensing or administration is in accordance with regulations of the Board of Pharmacy.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Acts of Assembly Chapter text (CHAP0731) (committee substitute) — source
  2. Bill text as passed House and Senate (HB1506ER) (committee substitute) — source
  3. Engrossed by House - committee substitute HB1506H1 (committee substitute) — source
  4. Impact statement from DPB (HB1506) (committee substitute) — source
  5. Impact statement from DPB (HB1506H2) (committee substitute) — source
  6. Impact statement from DPB (HB1506S1) (committee substitute) — source

Votes

  • Reported from Health, Welfare and Institutions with substitute (18-Y 0-N) — 180 (pass) · lower
  • Conference report agreed to by Senate (37-Y 2-N) — 372 (pass) · upper
  • Passed Senate with substitute (40-Y 0-N) — 400 (pass) · upper
  • Senate insisted on substitute (40-Y 0-N) — 400 (pass) · upper
  • Constitutional reading dispensed (37-Y 0-N) — 370 (pass) · upper
  • VOTE: Adoption (96-Y 2-N) — 952 (pass) · lower
  • VOTE: REJECTED (0-Y 98-N) — 097 (fail) · lower
  • VOTE: Passage (94-Y 2-N) — 932 (pass) · lower
  • Reported from Education and Health with substitute (15-Y 0-N) — 150 (pass) · upper

Sponsors

  • Mark D. Sickles — primary (person)
  • James E. Edmunds, II — cosponsor (person)
  • Kaye Kory — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2020-01-08 Presented and ordered printed 20105023D introduction
  • 2020-01-08 Referred to Committee on Health, Welfare and Institutions referral-committee
  • 2020-01-29 Impact statement from DPB (HB1506)
  • 2020-02-05 House committee, floor amendments and substitutes offered
  • 2020-02-06 House committee, floor amendments and substitutes offered
  • 2020-02-06 Reported from Health, Welfare and Institutions with substitute (18-Y 0-N) committee-passage
  • 2020-02-06 Committee substitute printed 20107565D-H1 substitution
  • 2020-02-09 Read first time reading-1
  • 2020-02-10 Read second time reading-2
  • 2020-02-10 Committee substitute agreed to 20107565D-H1
  • 2020-02-10 Engrossed by House - committee substitute HB1506H1
  • 2020-02-11 Read third time and passed House (94-Y 2-N) passage, reading-3
  • 2020-02-11 VOTE: Passage (94-Y 2-N)
  • 2020-02-12 Constitutional reading dispensed
  • 2020-02-12 Referred to Committee on Education and Health referral-committee
  • 2020-02-14 Impact statement from DPB (HB1506H1)
  • 2020-02-27 Reported from Education and Health with substitute (15-Y 0-N) committee-passage
  • 2020-02-27 Committee substitute printed 20109069D-S1 substitution
  • 2020-02-27 Impact statement from DPB (HB1506S1)
  • 2020-02-28 Constitutional reading dispensed (37-Y 0-N)
  • 2020-03-02 Read third time reading-3
  • 2020-03-02 Reading of substitute waived
  • 2020-03-02 Committee substitute agreed to 20109069D-S1
  • 2020-03-02 Engrossed by Senate - committee substitute HB1506S1
  • 2020-03-02 Passed Senate with substitute (40-Y 0-N) passage
  • 2020-03-03 Placed on Calendar
  • 2020-03-03 Senate substitute rejected by House 20109069D-S1 (0-Y 98-N)
  • 2020-03-03 VOTE: REJECTED (0-Y 98-N)
  • 2020-03-04 Senate insisted on substitute (40-Y 0-N)
  • 2020-03-04 Senate requested conference committee
  • 2020-03-05 House acceded to request
  • 2020-03-05 Conferees appointed by House
  • 2020-03-05 Conferees appointed by Senate
  • 2020-03-07 Amended by conference committee
  • 2020-03-07 Conference substitute printed 20109812D-H2
  • 2020-03-07 Conference report agreed to by House (96-Y 2-N)
  • 2020-03-07 VOTE: Adoption (96-Y 2-N)
  • 2020-03-08 Conference report agreed to by Senate (37-Y 2-N)
  • 2020-03-09 Impact statement from DPB (HB1506H2)
  • 2020-03-18 Enrolled
  • 2020-03-18 Signed by President
  • 2020-03-19 Signed by Speaker
  • 2020-03-20 Impact statement from DPB (HB1506ER)
  • 2020-03-20 Enrolled Bill communicated to Governor on March 20, 2020
  • 2020-03-20 Governor's Action Deadline 11:59 p.m., April 11, 2020
  • 2020-04-06 Approved by Governor-Chapter 731 (effective 7/1/20) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/a2f3a038-9cdb-4837-b7d5-5aaba7759216. Confidence: reported (aggregated from official Virginia legislature records).